Name: Total Asset Turnover

Definition: Total asset turnover measures how efficiently the company generates sales from its entire asset base. A high turnover means the company gets a lot of sales out of relatively fewer assets — very efficient. A low turnover may suggest underused assets or bloated balance sheets.

Interpretation:
• In '2021', SNTI's total asset turnover was 0.02, reflecting overall efficiency in utilizing assets. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2021' stood at 0.13.
• In '2022', SNTI's total asset turnover was 0.02, reflecting overall efficiency in utilizing assets. The figure remained stable compared to '2021'. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2022' stood at 0.13. Industry average increased by 0.00 compared to previous year.
• In '2023', SNTI's total asset turnover was 0.01, reflecting overall efficiency in utilizing assets. The decline from '2022' may indicate some operational or financial challenges. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2023' stood at 0.13. Industry average declined by 0.00 from previous year.
• In '2024', SNTI's total asset turnover was 0.00, reflecting overall efficiency in utilizing assets. The decline from '2023' may indicate some operational or financial challenges. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2024' stood at 0.16. Industry average increased by 0.03 compared to previous year.
Overall, SNTI's total asset turnover has been volatile but showed a downward trend over the past 4 years.

Formula: Total Asset Turnover = Net Sales / Total Assets

Good Range: Ranges from 0.5 to 2 depending on business type.